A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis
NCT07747155
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis (UC)
Interventions
DRUG:
PTT-621 Tablets
Sponsor
Pyrotech Therapeutics, Inc.